SEC is proposing to codify and revise notifications prescribing rules on the operating systems and service provision of securities companies and derivatives business operators to be more
principles in Section 77 of the Constitution.“On the occasion of the 28th anniversary, SEC has implemented the Regulatory Guillotine scheme that aims to revise regulations in all aspects for the Thai capital
SEC has plans to review the criteria relating to the report form of the securities and derivative business operators to accommodate the change in financial reporting standards - financial instrument that will be effective from 1 January 2020. The report form will be revised to be in line with the financial statement form which has recently been revised. In addition, SEC considers it reasonable to increase the flexibility in submitting the report to be in line with the operation procedu...
SEC considers revising the regulations on the offering for sale of investment in shares held by listed companies or their subsidiaries in order that the shareholding can be conveniently restructured before any merger and acquisition. In the case of investments in shares of public limited companies, the filing of the registration statement and draft prospectus will be exempted. In the case of investment in shares of limited companies, these can be offered for sale to more than 50 investors...
SEC is proposing to amend the regulations on the capital requirements for asset management companies that manage property funds or infrastructure funds, trust managers and trustees of REITs or infrastructure trusts to ensure that they have adequate and suitably high levels of capital. Under the proposed amendments, the initial capital requirement or the minimum amount of owner’s equity must be maintained at 10 million baht for trust managers of REITs or infrastructure trusts and 20 million...
Date of EGM 1/2020 (Revise) Dear Directors and Managers Stock of Exchange of Thailand Attachment 1. Extraordinary General Meeting of Shareholders No. 1/2020 2. Information Regarding the Asset Acquisition
Microsoft Word - IP_OCS_011 มติ BOD4_T 2020_revise บร ิษัท อ ินเตอร ์ฟารม์า จาํกัด (มหาชน) เลขท ี / อาคารไอทเีอฟ ชัน ถนนสีลม แขวงสุร ิยวงศ ์เขตบางร ัก กรุงเทพมหานคร โทรศัพท ์ - - แฟ็กซ ์ - 34-0135 www.interpharma.co.th Inter Pharma Public Company Limited 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th IP_OCS/011/2563 8 มิถนุายน 2563 เรอืง แจง้มติทีประชมุคณะกรรมการบรษัิท, การเปลียนแปลงวตัถปุระสงคก์ารใชเ...
Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise Data not found Last updated on 31 March 2022